The endothelin system and its antagonism in chronic kidney disease.
The incidence of chronic kidney disease (CKD) is increasing worldwide. Cardiovascular disease (CVD) is strongly associated with CKD and constitutes one of its major causes of morbidity and mortality. Treatments that slow the progression of CKD and improve the cardiovascular risk profile of patients with CKD are needed. The endothelins (ET) are a family of related peptides, of which ET-1 is the most powerful endogenous vasoconstrictor and the predominant isoform in the cardiovascular and renal systems. The ET system has been widely implicated in both CVD and CKD. ET-1 contributes to the pathogenesis and maintenance of hypertension and arterial stiffness and more novel cardiovascular risk factors such as oxidative stress and inflammation. Through these, ET also contributes to endothelial dysfunction and atherosclerosis. By reversal of these effects, ET antagonists may reduce cardiovascular risk. In particular relation to the kidney, antagonism of the ET system may be of benefit in improving renal hemodynamics and reducing proteinuria. ET likely also is involved in progression of renal disease, and data are emerging to suggest a synergistic role for ET receptor antagonists with angiotensin-converting enzyme inhibitors in slowing CKD progression.
Dhaun
Neeraj
N
The Queen's Medical Research Institute, 3rd Floor East, Room E3.23, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. bean.dhaun@ed.ac.uk
Goddard
Jane
J
Webb
David J
DJ
D000818:Animals; D050197:Atherosclerosis / Q000503:physiopathology; D002908:Chronic Disease; D016232:Endothelins / Q000037:antagonists & inhibitors* / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D018836:Inflammation Mediators / Q000502:physiology; D007668:Kidney / Q000098:blood supply / Q000503:physiopathology; D007674:Kidney Diseases / Q000188:drug therapy / Q000503:physiopathology*; D008954:Models, Biological; D018384:Oxidative Stress; D012084:Renin-Angiotensin System / Q000502:physiology; D014655:Vascular Resistance / Q000502:physiology
D016232:Endothelins; D018836:Inflammation Mediators